Elterman, Dean Sol <br/><br/>
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.  [electronic resource] 

 -  The Journal of urology  May 2010 
 - 2085-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1527-3792 
<br/><br/><label>Standard No.: </label>10.1016/j.juro.2009.12.097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenergic alpha-Antagonists--chemistry<br/>Azasteroids--chemistry<br/>Capsules<br/>Cholestenone 5 alpha-Reductase--antagonists & inhibitors<br/>Chromatography, High Pressure Liquid<br/>Doxazosin--chemistry<br/>Drug Contamination<br/>Dutasteride<br/>Enzyme Inhibitors--chemistry<br/>Finasteride--chemistry<br/>Humans<br/>Male<br/>Phytotherapy<br/>Prazosin--analogs & derivatives<br/>Prostatic Hyperplasia--drug therapy<br/>Quinazolines--chemistry<br/>Sulfonamides--chemistry<br/>Tablets<br/>Tamsulosin